Seragon Pharmaceuticals' Spinoff / Spinout Round

Seragon Pharmaceuticals raised a round of funding on August 20, 2013. Investors include Aragon Pharmaceuticals.

Seragon is focused on developing new treatments for estrogen-driven cancers based on its Selective Estrogen Receptor Degrader (SERD) platform. Seragon Pharmaceuticals' orally active selective estrogen…

Articles about Seragon Pharmaceuticals' Spinoff / Spinout Round: